Andere talen 2cureX AB

Aandelen

2CUREX

SE0010468124

Vertraagde tijd Nasdaq Stockholm Andere beurzen 15:15:03 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,38 ^SEK	-19,15%		-5,00%	-81,09%

29/02	2curex AB (publ) kiest Grith Hagel als nieuw bestuurslid	CI
22/02	2cureX AB (publ) rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS	16/03
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	29/02
2curex AB Elects Grith Hagel as a New Board Member	29/02
2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024	22/02
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	12/02
2cureX AB Announces Change to the Board of Directors	04/01
2cureX AB Announces CEO Changes	29/12
2cureX AB Announces Executive Changes, Effective 1 January 2024	29/12
2cureX Makes Executive Changes Amid Planned Global Expansion of IndiTreat Tests; Shares Drop	29/12
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	06/12
2cureX publishes interim report for the third quarter of 2023	23/11
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	14/11
2Curex AB Appoints Tonni Bülow-Nielsen as Board Member and Chairman	14/11
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System	26-10-23
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	25-10-23
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests	11-10-23
2curex Launches Its First Two IndiTreat® Products Ce-Marked Under the New Ivd Regulation	30-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen 2cureX AB

Aandelen

2CUREX

SE0010468124

Andere talen

Filters